• OPEN AN ACCOUNT
Indian Indices
Nifty
22,326.90 203.25
(0.92%)
Sensex
73,651.35 655.04
( 0.90%)
Bank Nifty
47,124.60 338.65
( 0.72%)
Nifty IT
34,898.15 153.80
( 0.44%)
Global Indices
Nasdaq
16,379.46 -20.06
(-0.12%)
Dow Jones
39,807.37 47.29
(0.12%)
Hang Seng
16,541.42 148.58
(0.91%)
Nikkei 225
40,369.44 201.37
(0.50%)
Forex
USD-INR
83.34 0.01
(0.01%)
EUR-INR
90.21 -0.13
(-0.15%)
GBP-INR
105.20 -0.12
(-0.11%)
JPY-INR
0.55 0.00
(-0.01%)

EQUITY - MARKET SCREENER

Lupin receives EIR for its Ankleshwar manufacturing facility
02-Oct-22   18:00 Hrs IST
Lupin announced that it has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (US FDA) for its Ankleshwar manufacturing facility, located in Gujarat, India. The inspection of the facility was conducted from 16-19 August 2022.

Powered by Capital Market - Live News